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Abstract 
Purpose: To compare the effects of laser and/or L-carnitine (LC) on amiodarone (AM)-induced lung 
toxicity in adult male rats. 
Methods: Lung toxicity was induced in 50 healthy male albino rats (150-180 g) by AM for 8 weeks. The 
rats were divided into 4 groups (7 per group): AM recovery, LC, laser, and laser + LC. After a 4-week 
exposure to laser and/or LC, key antioxidant enzymes, nitric oxide (NO), angiotensin II, 
cyclooxygenase-II (COX-II) and lipoxygenase (LOX) as well as oxidative stress and inflammation 
parameters were determined. 
Results: Administration of LC and/or laser exposure led to significant increases in reduced glutathione 
(GSH), superoxide dismutase (SOD), catalase (CAT) and angiotensin II; and significant decreases in 
nitric oxide (NO) level and glutathione-S-transferase (GST) activity in the AM-treated rats when 
compared with the AM recovery group (p ˂ 0.05). The LC and/or laser exposure also significantly 
inhibited COX II and LOX activities in the lungs, and brought about significant reduction in levels of 
TNF-α and lipid peroxidation (LPO), and significant increases in cytochrome levels (p ˂ 0.05).  
Conclusion: These results indicate that AM induced pulmonary fibrosis in rats. However, AM 
withdrawal and treatment by LC and/or exposure to laser exerted mitigating effects against the AM-
induced fibrosis.  
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The lung is the primary organ of respiration in 
humans and many lower animals. Lung tissue 
may be affected by many diseases such as 
pneumonia, lung cancer and lung fibrosis, due to 
exposure to harmful substances. Pulmonary 
fibrosis is a lung disease characterized by 
scarring of lung tissue, leading to breathing 
problems and other symptoms. The fibrotic scar 
and excess accumulation of fibrous connective 
tissue thicken the walls of the lung tissue and 
reduce oxygen supply to the blood, leading to 
shortness of breath [1].  
 
Pulmonary toxicity is considered a life-
threatening complication of amiodarone usage. 
In medicine, most of pulmonary toxicity diseases 
are caused by side effects of drugs. Drug-
induced pulmonary toxicity can lead to fibrosis 
[2].  
 
Amiodarone (AM) is a derivative of iodine 
benzofuran HCl (marketed as Pacerone or 
Cordarone). It is considered the strongest and 
most effective anti-arrhythmic drug because it 
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surpasses other agents in its ability to prevent 
and treat ventricular and supraventricular 
dysrhythmias. However, the use of AM is often 
limited by adverse reactions involving many 
different organ systems [3]The toxicity of AM 
which manifests in pneumonia can be seen as 
adult respiratory distress syndrome (ARDS); it 
has a high rate of mortality (about 50% of 
patients) [4], and can lead to severe pulmonary 
fibrosis [5]. 
 
The carnitine system consists of L-carnitine 
(C7H15NO3), acetyl-carnitine (C9H17NO) and 
the cellular proteins which are required for 
metabolism and transport. L-carnitine consists of 
amino acids naturally produced in humans and 
lower animals. It plays a role as a carrier for 
translocation of long-chain fatty acids from the 
cytosol into the mitochondria for β-oxidation [6]. 
 
The use of low levels of visible light to reduce 
inflammation-related pain, promote healing of 
deep wounds in tissues and nerves, and prevent 
tissues from damage have been documented 
These applications are based on the fact that 
that low level (soft-cold) lasers do not have 
thermal effects on tissues: lasers that stimulate 
biological function have an output below 10 
milliwatts [7]. The effect of laser on tissue 
depends on the absorption of monochromatic 
visible rays by the components of the cellular 
respiratory chain of mitochondria. Evidence 
shows that treatment by laser light (low-level) 
induces the mitochondria to increase ATP 
production [8].   
 
The present study focused on the potential 
therapeutic effects of L-carnitine and laser, either 
singly or synergistically, on lung toxicity induced 






Amiodarone (AM, empirical formula C25 H29 I2 
NO3) and L-carnitine (3-hyroxy, 4-trimethylamino 
butyric acid) were obtained from Sigma Chemical 
Company (USA). Therapeutic low-intensity red 
laser module with more patterns projector was 
purchased from Shenzhen Light Technology Co. 




Healthy 50 adult male albino rats (150 – 180 g, 
aged 6 - 7 weeks were used in this study. They 
were obtained from Medical and Bilharzia 
Research Center, Faculty of Medicine, Ain 
Shams University, Egypt.  
The animals were housed in separate cages at 
room temperature (22 ± 4 ° C), with free access 
to water and feed. Blood parasitological tests and 
clinical examination were performed to ensure 
the animals were healthy. Amiodarone and L-
carnitine were administered at doses of 30 and 
100 mg/kg body weight, for 8 weeks and 30 
days, respectively by oro-gastric tube [9, 10]. 
 
The study procedures were performed in line 
with the ethical guide for the care and use of 
laboratory animals of theU.S. National Research 
Council of the National Academics [11]. 
 
The experimental procedures were approved by 
theInstitutional Animal Care and Use Committee 
(IACUC), Faculty of Science, Menofia University, 




The rats were randomly assigned to five groups, 
each containing 7 animals: (i) control group: rats 
received 0.5 ml distilled water through oro-gastric 
tube; (ii) AM recovery group: rats in this group 
did not receive any treatment for 30 days after 
exposure to AM (30 mg / kg/ BWT) for 60 days 
[10]; (iii) AM+LC group: after exposure to AM (30 
mg/kg BWT) for 60 days, the rats received LC 
(100 mg/kg BWT) for 30 days [9], and (iv) AM + 
laser group: after AM exposure, the rats were 
exposed to laser [12] and (v) LC + laser: after 
AM treatment, the rats exposed to laser and 
received L-carnitine for 30 days.  
 
Exposure of animals to laser light  
 
The rats were anesthetized with ketamine (80 
mg/kg) and xylazine (10 mg/kg/ BWT) [12]. 
Before exposure to laser light, hair was removed 
from 4 cm2 of abdominal area of each rat. Then, 
1cm2 of the lung-facing area was exposed to 
laser light (650 nm) for 2 minutes. On the 30th 
day of exposure, the rats were sacrificed then 
serum and lung tissue samples were collected 




The comet assay was done under alkaline 
conditions, including the unwinding of DNA to 
detect combination of DNA (single, double) 
strand breaks and alkali-labile sites in the DNA 
[3]. 
 
Statistical analysis   
 
Data on lung parameters were expressed with 
mean ± standard deviation. Statistical analysis 
was performed using ANOVA to analyze data in 
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SPBS version 10. Values of p< 0 05 were taken 




Antioxidant levels  
 
Treatment of the rats with AM induced oxidative 
stress as demonstrated by significant decreases 
in GSH, SOD, CAT and Angiotensin II, which 
were accompanied by significant elevations in 
NO and GST contents when compared with 
control group (p< 0.05; Table 1). Oral 
administration of LC and/or exposure of the AM-
treated rats to laser led to significant elevations 
in GSH and angiotensin II levels, and in the 
activities of SOD and CAT, with concomitant 
significant decreases in NO and GST contents, 
relative to AM-treated rats (p < 0.05). 
 
Lung COX II and LOX activities  
 
The administration of AM resulted in significant 
elevation in COX II and LOX activities in lung 
tissue when compared with the control group (p 
˂ 0.05; Table 2). However, the activities of these 
two enzymes were significantly decreased in the 
AM-treated rats by LC and/ or laser exposure, 
relative to AM-treated rats (p ˂ 0.05; Table 2).  
 
Oxidative stress and inflammation status 
 
The results also showed that AM induced 
significant increases in serum TNF-α and LPO 
product when compared with control group (p ˂ 
0.05; Table 2). However, LC and/or laser 
exposure led to significant reductions in TNF-α 
and in the degree of lipid peroxidation in AM-
treated rats (p ˂ 0.05; Table 2).  
 
Changes in cytochromes P4501A2 (CYP1A2) 
and P4502E1 (CYP2E1) 
 
Table 2 also shows that serum levels of 
cytochromes CYP1A2 and CYP2E1 were 
significantly higher in the AM-treated rats when 
compared with the normal control (p ˂ 0.05). On 
the other hand, treatment of the AM rats with LC 
and/or exposure to laser (Figure 1) significantly 
reduced the levels of CYP1A2, CYP2E1 relative 
to AM rats (p ˂ 0.05). 
 
 
Table 1: Effect of L-carnitine or/and laser on antioxidants (GSH, GST, SOD, and CAT), NO and angiotensin II 
levels in lung tissue of AM-treated rats (mean ± SEM) 
 








































































Values are expressed as mean ± SEM (n = 10, p < 0.05) 
 
Table 1: Effect of L-carnitine or/and Laser on the lung enzymes (COX, LOX), oxidative stress &inflammatory 
status (TNF-α, MDA) and cytochromes (CYP 1A2, CYP 2E1) contents in Amiodarone treated rats 
 
Group & treatment 










































































Values are expressed as mean ± SEM (n = 10, p < 0.05)  
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            Table 3: DNA damage in rats 
 
Group & treatment Head/1000(mean ± SEM) 
DNA in 





Control  2.1  ±0.20 33.8 
20.61 
±2.1 62.2 
AM recovery 5.9 ±0.20 20.6 
30.51 
±3.5 79.4 
AM + L-Carnitine 4.5 ±0.52 27.7 
28.51 
±3.1 72.3 
AM + Laser 4.01 ±0.55 29.6 
26.1 
±2.5 70.4 




                            
Control Group                                                                    AM Recovery group (30 days) 
   
                         
AM + L-Carnitine group (30 days)                                      AM + Laser group (30 days)  
 
  
AM + L-carnitine + laser group (30 days) 
 
Figure 1: Images of fragment and pattern of DNA migration by comet assay evaluated with a 




Results from several studies have suggested that 
oxidant-antioxidant imbalance in the lower 
respiratory system plays a crucial role in 
pulmonary toxicity. Amiodarone administration 
results in interstitial alveolar inflammation [10]. In 
the present study, the administration of AM to 
rats induced marked elevations in NO and GST, 
and significant reductions in GSH, SOD, CAT 
and Angiotensin II when compared with control 
rats. These changes can be attributed to AM-
induced pulmonary toxicity. Several mechanisms 
are involved in the accumulation of iodine-rich 
AM in pneumocytes [14]. The mechanisms 
involve direct toxic effect that disrupts cellular 
membranes through the activation of protein 
kinase C, release of toxic reactive oxygen 
species (ROS), decreases in GSH, mitochondrial 
dysfunction, necrosis and ultimately apoptosis 
[15]. Amiodarone treatment has been reported to 
increase generation of free radicals, and 
production of mitochondrial hydrogen peroxide 
which could be metabolized to an aryl radical that 
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may give rise to other ROS [16]. The strong 
oxidizing potential of ROS can lead to generation 
of advanced oxidation products and induce 
damage to cellular structures within the lungs. In 
addition, GSH plays an important role in a variety 
of detoxification processes. It has been reported 
that AM significantly reduced GSH levels in rat 
lung homogenate, suggesting its oxidation-
induced role in lung toxicity [17]. 
 
The most important antioxidant enzymes in the 
lung are SOD and CAT. These antioxidant 
enzymes are the first lines of defense against 
oxidative damage [10]. Alveolar macrophages 
isolated from AM-treated rats released large 
amounts of TNF-α [18]. Pulmonary toxicity by AM 
is an immuno-mediated process involving an 
imbalance in T-helper cells and over-production 
of cytokines which are reported to significantly 
increase serum TNF-α [14].In addition, the 
oxidative capacity of ROS leads to generation of 
oxidation products and cellular damage within 
the lungs. Malondialdehyde (MDA) is an index of 
membrane LPO which damages pulmonary 
endothelium [17]. 
 
L-carnitine is a very effective antioxidant agent. 
In this study, LC significantly increased the levels 
of GSH, GST, SOD and NO. This is in 
agreement with a previous report on the 
antioxidant and free radical-scavenging 
properties of LC [19]. It has been suggested that 
LC is involved in ATP synthesis through its role 
in mobilization of mitochondrial fatty acids during 
β-oxidation. During ATP synthesis, massive 
oxygen consumption depletes oxygen and ROS 
levels. The anti-oxidant effect of LC is thought to 
be due its ability to increase the activity of 
antioxidant enzymes [20,21]. 
Laser therapy restores the balance between 
oxidants and antioxidants [22]. This is in 
agreement with the laser-induced significant 
increases in antioxidant parameters seen in the 
present study. The synergistic effects of laser 
and LC led to significant increases in GSH, SOD, 
CAT, GST and angiotensin II, as well as 
significant decreases in NO. Thus the laser 
restored the balance between oxidant and 
antioxidants [23]. 
 
Special laser light near the infrared region (NIR) 
is used to reduce pain, inflammation, and edema. 
It is also used to promote healing of deep tissue 
wounds, and to protect the nerves and prevent 
tissue damage. These uses of laser light are 
based on its properties and its ability to interact 
with living tissue to produce energy (ATP). 
Interestingly, mammalian cell cytochrome c 
oxidase has uptake peaks in the NIR region. 
Mitochondria are the primary sites of light effects, 
production of ATP, modification of reactive 
oxygen species, and induction of transcription 
factors. These events, in turn, lead to increases 
in cell proliferation and migration, as well as 
increases in cytokine levels, growth factors, 
inflammatory mediators and tissue oxygenation. 
Changes in biochemical and cellular outcomes in 
animals and patients include benefits such as 
increased healing of chronic wounds, carpal 
tunnel syndrome, pain reduction in arthritis, 
neuropathy, as well as reduced damage after 




The effect of laser light at the cellular level 
(Figure 2) is based on the absorption of 
monochromatic visual radiation from by the 
components of the mitochondrial respiratory 
chain. The initial photoreceptor of red light is 
cytochrome C oxidase. Furthermore, absorption 
spectra obtained for cytochrome C oxidase and 
recorded in various oxidation states are similar to 
the spectra reflecting the biological responses to 
light [8]. Thus, laser light can stimulate biological 
processes in the mitochondria to produce 
energy, which is similar to what occurs within the 
mitochondria in the alveolar cells of the lung 
tissue. 
 
Figure 2: Therapeutic effect of laser light on tissues 
 
Studies have accounted for how the absorption 
of photon produces laser energy [25]. Absorption 
of photons by molecules causes electron 
excitation, resulting in accelerated electron 
transfer. This transport increases ATP 
production, and also increases light-induced ATP 




The findings of this study demonstrate that 
prolonged administration of AM in rats induces 
lung fibrosis. Thus, withdrawal of AM and 
treatment by LC and/or exposure to laser can 
potentially produce significant amelioration of 
AM-induced fibrosis. 
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